A. Leandro Barros , M.C. Monedero Martín , J. Serpa Morán , C. Tejada González , A. Ruiz-Saavedra , A. García Lledó
{"title":"Insuficiencia cardíaca: epidemiología, mecanismos etiopatogénicos y clasificación","authors":"A. Leandro Barros , M.C. Monedero Martín , J. Serpa Morán , C. Tejada González , A. Ruiz-Saavedra , A. García Lledó","doi":"10.1016/j.med.2025.06.010","DOIUrl":null,"url":null,"abstract":"<div><div>Heart failure (HF) is a syndrome characterized by the presence of signs and symptoms of systemic/pulmonary congestion and/or low output. Its prevalence is increasing and it has a high mortality rate. It may be due to multiple cardiac and some extracardiac conditions. The key elements for diagnosis are the medical history, physical examination, natriuretic peptides determination, and echocardiogram. Knowing the left ventricular ejection fraction is essential, since it defines groups with different etiopathogenesis, management, and prognosis. Activation and maintenance of the neurohormonal axis is the main trigger for disease progression in HF. In addition, there is ventricular remodeling as an adaptation to volume or pressure overload, either by heart chamber dilation or by ventricular hypertrophy. Treatment aimed at the cause and neurohormonal axis blockade is key to management and has prognostic implications in patients with HF with reduced ejection fraction.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 35","pages":"Pages 2105-2113"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541225001532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Heart failure (HF) is a syndrome characterized by the presence of signs and symptoms of systemic/pulmonary congestion and/or low output. Its prevalence is increasing and it has a high mortality rate. It may be due to multiple cardiac and some extracardiac conditions. The key elements for diagnosis are the medical history, physical examination, natriuretic peptides determination, and echocardiogram. Knowing the left ventricular ejection fraction is essential, since it defines groups with different etiopathogenesis, management, and prognosis. Activation and maintenance of the neurohormonal axis is the main trigger for disease progression in HF. In addition, there is ventricular remodeling as an adaptation to volume or pressure overload, either by heart chamber dilation or by ventricular hypertrophy. Treatment aimed at the cause and neurohormonal axis blockade is key to management and has prognostic implications in patients with HF with reduced ejection fraction.